Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2009-05-12 Net Asset Value
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is extremely short (245 characters) and appears to be a formal announcement from a company listed on the OMX Nordic Exchange Copenhagen. The content explicitly states the 'Indre værdi' (Net Asset Value or NAV) calculated for a specific date (May 12, 2009) as 39.12. This directly corresponds to the definition of a Net Asset Value update, which is classified as 'NAV'.
2009-05-12 English
Regulatory Filings 2009
Regulatory Filings
2009-05-12 Danish
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is extremely short (245 characters) and is titled "Fondsbørsmeddelelse" (Stock Exchange Announcement). The content explicitly states the 'Indre værdi' (Net Asset Value or NAV) calculated for a specific date (May 11, 2009) as 39.22. This directly corresponds to the definition of a Net Asset Value update, which is classified as NAV.
2009-05-11 English
Regulatory Filings 2009
Regulatory Filings
2009-05-11 Danish
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is extremely short (244 characters) and announces a specific financial metric, the 'Indre værdi' (Net Asset Value), for a specific date (May 7, 2009). This directly corresponds to the definition of Net Asset Value updates, primarily for investment funds. The filing type code NAV (Net Asset Value) is the most appropriate classification. It is not an announcement of a report publication (RPA) because it contains the core data point itself, not just a notice that a report is available.
2009-05-07 English
Regulatory Filings 2009
Regulatory Filings
2009-05-07 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.